Evidence map›Paper›PMID 19675352›Full record

ReviewPhysiology (Bethesda, Md.)2009

Engineering proteins for custom inhibition of Ca(V) channels.

Xianghua Xu, Henry M Colecraft

Abstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Engineering selectivity into RGK GTPase inhibition of voltage-dependent calcium channels.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  4. Article
  5. Article
  6. Ion channel engineering: perspectives and strategies.Journal of molecular biology · 2015
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xianghua XuDepartment of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Henry M Colecraft

Funding

Molecular Determinants of L-type Calcium Channel GatingR01HL069911 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLECRAFT, HENRY M. · 2002 to 2011
$3.3M
RGK GTPases/Ca2+ Channel Cross TalkR01HL084332 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLECRAFT, HENRY M. · 2007 to 2010
$1.6M
NHLBI NIH HHS R01 HL069911NHLBI NIH HHS R01 HL084332
6 · The paper itself

Abstract

The influx of Ca(2+) ions through voltage-dependent calcium (Ca(V)) channels links electrical signals to physiological responses in all excitable cells. Not surprisingly, blocking Ca(V) channel activity is a powerful method to regulate the function of excitable cells, and this is exploited for both physiological and therapeutic benefit. Nevertheless, the full potential for Ca(V) channel inhibition is not being realized by currently available small-molecule blockers or second-messenger modulators due to limitations in targeting them either to defined groups of cells in an organism or to distinct subcellular regions within a single cell. Here, we review early efforts to engineer protein molecule blockers of Ca(V) channels to fill this crucial niche. This technology would greatly expand the toolbox available to physiologists studying the biology of excitable cells at the cellular and systems level.

Indexed as

Calcium Channel BlockersAnimalsCalcium ChannelsHeartHumansMyocardiumNeuronsProtein EngineeringCalcium Channel BlockersCalcium Channels

Identifiers

PMID19675352
PMCPMC2841218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.